The treatment of terminal metamorphosis of chronic granulocytic leukaemia with corticosteroids and vincristine.
D000208:Acute Disease; D001856:Bone Marrow Examination; D002471:Cell Transformation, Neoplastic; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use*
D005938:Glucocorticoids; D014750:Vincristine; D003907:Dexamethasone; D011239:Prednisolone; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate